Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed AML

NCT01829503 is registered in ClinicalTrials.gov with Annie Im, M.D. as lead sponsor.

NCT NCT01829503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01829503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed AML
Lead sponsor
Annie Im, M.D.
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2013
Completion date
November 30, 2017
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia